Sanofi Launches C$925 Million Toronto Facility to Boost Influenza Vaccine Production | AR1N

By DRM News

Community Score: 50% | 24 views | 4w

0 community ratings: null thumbs up, null thumbs down

Sanofi inaugurates the Charles Best Building in Toronto, a $925 million influenza vaccine manufacturing facility designed to strengthen Canada’s domestic vaccine supply and pandemic preparedness. The facility will manufacture Fluzone High-Dose influenza vaccine for older adults and can pivot toward pandemic influenza production. Sanofi also highlights its $294 million Toronto AI expansion and more than a century of operations in Canada. For more details, watch our story and subscribe to our channel, DRM News. Sanofi, Sanofi Toronto, Charles Best Building, Toronto vaccine facility, Canada vaccine manufacturing, influenza vaccine, flu vaccine, Fluzone High Dose, Sanofi vaccine, Canadian biomanufacturing, vaccine manufacturing, pandemic preparedness, Canada health security, Melanie Joly, Toronto, Ontario, life sciences, pharmaceutical industry, vaccine production, DRM News #Sanofi #Toronto #Canada #Vaccine #InfluenzaVaccine #FluVaccine #Biomanufacturing #PandemicPreparedness #Healthcare

Tags: Doug Ford, Doug Ford press conference, Ontario Premier, Ontario, Toronto, Toronto news, Olivia Chow, Mélanie Joly, Marjorie Michel, Canada, Canadian politics, Ontario government, Toronto government, federal government Canada, Toronto press conference, Ford news conference, Ontario news, Canada news, DRM News